Before 50 years of age, 21% of path_MLH1 and path_MSH2 carriers underwent hysterectomy compared with only 13% of path_MSH6 carriers, despite the latter having similar cumulative risk for endometrial cancer. The gene discussed is MSH2; the disease is endometrial cancer.